Disease progression means a disease is getting worse over time, spreading, growing, or causing more symptoms. In cancer, it refers to a tumor growing or spreading despite treatment, or after a period of stability. Doctors track progression with scans, blood tests, and symptoms to guide treatment decisions.
Origin
The concept is basic to clinical medicine and oncology. A standardized way to measure it in cancer, the RECIST criteria for solid tumors, was formalized in 2000 to give consistent definitions of progression across studies and clinics.
Significance in Asbestos Context
For someone with mesothelioma or asbestos-related lung cancer, progression often marks a turning point, prompting a change in treatment or a shift toward comfort-focused care. Documented progression, tumor growth on imaging, more fluid, worsening breathing, records how the illness has advanced. These records matter to a claim because they show the disease's course, its effect on the person's life, and part of the basis for damages. Ask how progression is being measured and what options remain.
Example Sentence
His latest CT scan showed disease progression, so the oncologist discussed switching to a second-line therapy.
Related Terms
RECIST Criteria, Metastasis, Prognosis, Palliative Care, Restaging
Notes
- Ask how progression is being measured and what treatment options remain at each step.
- Keep copies of serial scan reports; they document the disease's course over time.
- Note new or worsening symptoms with dates; this record supports both care and any claim.
In the research library
208 studies in our medical research library mention Disease Progression in the title or abstract. Among the most cited:
- p53 autoantibodies in patients with malignant mesothelioma: stability through disease progressionJ. Creaney, B.M. McLaren, S. Stevenson, et al, 2001 · British Journal of Cancer · cited 17 times
- Methylation profile landscape in mesothelioma: possible implications in early detection, disease progression, and therapeutic optionsX. Zhang, N. Tang, A.K. Rishi, et al, 2015 · Methods in Molecular Biology · cited 12 times
- Disease progression in patients with usual interstitial pneumonia and probable UIP patterns on computed tomography with various underlying etiologies: a retrospective cohort studyS. Yang, J. Wang, D. Sun, et al, 2023 · Frontiers in Medicine · cited 10 times
- Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decorticationA. Bille, S. Chicklore, L. Okiror, et al, 2013 · Nuclear Medicine Communications · cited 10 times
- Expression of palladin is associated with disease progression in metastatic high-grade serous carcinomaB. Davidson, A.J. Bock, A. Holth, et al, 2020 · Cytopathology · cited 3 times
The journals that publish most on it: Lung Cancer (10), Cancers (8), Curēus (7).
Category: Diseases & Conditions · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.